Form 8-K - Current report:
SEC Accession No. 0001213900-17-013436
Filing Date
2017-12-19
Accepted
2017-12-19 17:29:56
Documents
3
Period of Report
2017-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121717_aytubioscience.htm 8-K 31356
2 EMPLOYMENT AGREEMENT, BY AND BETWEEN AYTU BIOSCIENCE, INC. AND DAVID A. GREEN, E f8k121717ex10-1_aytubio.htm EX-10.1 133570
3 PRESS RELEASE, DATED DECEMBER 18, 2017 f8k121717ex99-1_aytubio.htm EX-99.1 10607
  Complete submission text file 0001213900-17-013436.txt   177023
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 171264989
SIC: 2834 Pharmaceutical Preparations